6.
Janeczko M, Gmur D, Kochanowicz E, Gorka K, Skrzypek T
. Inhibitory effect of a combination of baicalein and quercetin flavonoids against Candida albicans strains isolated from the female reproductive system. Fungal Biol. 2022; 126(6-7):407-420.
DOI: 10.1016/j.funbio.2022.05.002.
View
7.
Harder E, Damm W, Maple J, Wu C, Reboul M, Xiang J
. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. J Chem Theory Comput. 2015; 12(1):281-96.
DOI: 10.1021/acs.jctc.5b00864.
View
8.
Anand David A, Arulmoli R, Parasuraman S
. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn Rev. 2017; 10(20):84-89.
PMC: 5214562.
DOI: 10.4103/0973-7847.194044.
View
9.
Georgiou N, Kakava M, Routsi E, Petsas E, Stavridis N, Freris C
. Quercetin: A Potential Polydynamic Drug. Molecules. 2023; 28(24).
PMC: 10745404.
DOI: 10.3390/molecules28248141.
View
10.
Wang R, Yang L, Li S, Ye D, Yang L, Liu Q
. Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM). Med Sci Monit. 2018; 24:412-420.
PMC: 5788241.
DOI: 10.12659/msm.908022.
View
11.
Ghafouri-Fard S, Khoshbakht T, Hussen B, Dong P, Gassler N, Taheri M
. A review on the role of cyclin dependent kinases in cancers. Cancer Cell Int. 2022; 22(1):325.
PMC: 9583502.
DOI: 10.1186/s12935-022-02747-z.
View
12.
Amat-Ur-Rasool H, Ahmed M, Hasnain S, Ahmed A, Carter W
. In Silico Design of Dual-Binding Site Anti-Cholinesterase Phytochemical Heterodimers as Treatment Options for Alzheimer's Disease. Curr Issues Mol Biol. 2022; 44(1):152-175.
PMC: 8929005.
DOI: 10.3390/cimb44010012.
View
13.
Lukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanislawek A
. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel). 2021; 13(17).
PMC: 8428369.
DOI: 10.3390/cancers13174287.
View
14.
Asgharian P, Tazekand A, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M
. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int. 2022; 22(1):257.
PMC: 9380290.
DOI: 10.1186/s12935-022-02677-w.
View
15.
Ali A, Banerjee S, Kamaal S, Usman M, Das N, Afzal M
. Ligand substituent effect on the cytotoxicity activity of two new copper(ii) complexes bearing 8-hydroxyquinoline derivatives: validated by MTT assay and apoptosis in MCF-7 cancer cell line (human breast cancer). RSC Adv. 2022; 11(24):14362-14373.
PMC: 8697721.
DOI: 10.1039/d1ra00172h.
View
16.
Nussinov R, Tsai C, Jang H
. Anticancer drug resistance: An update and perspective. Drug Resist Updat. 2021; 59:100796.
PMC: 8810687.
DOI: 10.1016/j.drup.2021.100796.
View
17.
Shultz M
. Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. J Med Chem. 2018; 62(4):1701-1714.
DOI: 10.1021/acs.jmedchem.8b00686.
View
18.
Sultan R, Ahmed A, Wei L, Saeed H, Islam M, Ishaq M
. The anticancer potential of chemical constituents of Moringa oleifera targeting CDK-2 inhibition in estrogen receptor positive breast cancer using in-silico and in vitro approches. BMC Complement Med Ther. 2023; 23(1):396.
PMC: 10625284.
DOI: 10.1186/s12906-023-04198-z.
View
19.
Moodi Z, Bagherzade G, Peters J
. Quercetin as a Precursor for the Synthesis of Novel Nanoscale Cu (II) Complex as a Catalyst for Alcohol Oxidation with High Antibacterial Activity. Bioinorg Chem Appl. 2021; 2021:8818452.
PMC: 7952193.
DOI: 10.1155/2021/8818452.
View
20.
Friesner R, Banks J, Murphy R, Halgren T, Klicic J, Mainz D
. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47(7):1739-49.
DOI: 10.1021/jm0306430.
View